Health Care & Life Sciences » Pharmaceuticals | Dong-A ST Co. Ltd.

Dong-A ST Co. Ltd. | Mutual Funds

Mutual Funds that own Dong-A ST Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total International Stock Index Fund
60,340
0.72%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
57,548
0.68%
0
0.01%
09/05/2018
Government Pension Fund - Global (The)
46,787
0.55%
-13,847
0%
12/31/2017
DFA Emerging Markets Small Cap Series
32,116
0.38%
0
0.04%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
31,535
0.37%
0
0.01%
04/30/2018
Vanguard Developed Markets Index Fund
25,538
0.3%
0
0%
07/31/2018
Mirae Asset TIGER 200
23,512
0.28%
229
0.08%
01/31/2018
Pacific Select Fund - International Small Cap Portfolio
18,666
0.22%
0
0.24%
05/31/2018
Mirae Asset TIGER Health Care ETF
12,696
0.15%
3,059
0.79%
04/30/2018
Vanguard FTSE All World (ex-US) Small Cap
12,370
0.15%
1,866
0.02%
07/31/2018
Illinois State Board of Investment
11,398
0.14%
2,895
0.01%
06/30/2016

About Dong-A ST Co.

View Profile
Address
64 Cheonhodae-ro
Seoul SL 02587
Korea, Republic Of
Employees -
Website http://www.donga-st.com
Updated 07/08/2019
Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products includes medicines for gastric mucous membrane protection, antihistanminic agetnts, ischemic improvements, antithrombotic, functional digestion, hyperlipemia cure, growth hormone, antipeptic ulcer cure, cerebral metabolic, high blood pressure, and others. The company was founded on March 4, 2013 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.